- CA$11.89m
- CA$11.61m
- CA$3.42m
- 66
- 92
- 40
- 73
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 0.458 | 0.288 | 0.28 | 0.286 | 0.282 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.038 | 0 | — | — | — |
Prepaid Expenses | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 17.7 | 18.7 | 23.3 | 24 | 25.1 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Liabilities | 0.326 | 0.265 | 0.284 | 0.301 | 0.316 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 17.4 | 18.5 | 23 | 23.7 | 24.8 |
Total Liabilities & Shareholders' Equity | 17.7 | 18.7 | 23.3 | 24 | 25.1 |
Total Common Shares Outstanding |